+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antihypertensive effects of a novel orally active angiotensin converting enzyme ace inhibitor altiopril calcium mc 838 in several hypertensive rat models



Antihypertensive effects of a novel orally active angiotensin converting enzyme ace inhibitor altiopril calcium mc 838 in several hypertensive rat models



Japanese Journal of Pharmacology 49(Suppl.): 214P




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030121781

Download citation: RISBibTeXText


Related references

Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril. Archives Internationales de Pharmacodynamie et de Therapie 292: 203-222, 1988

MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor. Tohoku Journal of Experimental Medicine 152(4): 363-374, 1987

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats. European Journal of Pharmacology 51(4): 377-388, 1978

Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats. Archives Internationales de Pharmacodynamie et de Therapie 292: 223-236, 1988

Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC-838) in spontaneously hypertensive rats. Journal of Pharmacy and Pharmacology 41(4): 279-280, 1989

Antihypertensive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Arzneimittel-Forschung 35(10): 1502-1507, 1985

Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs. Journal of Pharmacology and Experimental Therapeutics 216(2): 225-231, 1981

Hemodynamic and antihypertensive effects of captopril, an orally active angiotensin converting enzyme inhibitor. Hypertension 1(4): 397-401, 1979

Chronotropic and inotropic effects of a new angiotensin converting enzyme inhibitor, MC-838 (altiopril calcium), on the dog heart. Japanese Heart Journal 29(6): 841-848, 1988

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats. Japanese Journal of Pharmacology 29(2): 285-294, 1979

Antihypertensive activity in rats for SQ 14,225, an orally active inhibitor of angiotensin I-converting enzyme. Journal of Pharmacology and Experimental Therapeutics 204(2): 281-288, 1978

A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor. Journal of Pharmacobio-Dynamics 11(6): 411-415, 1988

Effects of an orally active converting-enzyme inhibitor, SQ 14225, on pressor responses to angiotensin administered into the brain ventricles of spontaneously hypertensive rats. Clinical Science 56(6): 585-589, 1979

Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent. Progress in Cardiovascular Diseases 21(3): 183-194, 1978

Antihypertensive effect of orally administered 6366A, and active metabolite of imidapril, a new angiotensin I-converting enzyme inhibitor. Pharmacometrics 46(5): 295-297, 1993